Literature DB >> 5954491

Coronary cineangiographic study of intravenously administered isoptin.

J D Mignault.   

Abstract

Since Isoptin increases coronary blood flow in the dog and improves patients with angina pectoris, the drug was studied by coronary cineangiography (Sones' technique) to determine the degree of vasodilatation so produced. When Isoptin, 5 mg. in 2 ml. of solvent, was injected intravenously into five patients with coronary disease and five without coronary disease, there was no change in the size of the main coronary vessels or in the degree of impregnation of the heart muscle, and no new vessels appeared. Isoptin produced a constant decrease in systolic, diastolic and mean blood pressure and a constant increase in heart rate.The clinical improvement in patients taking the drug may be independent of coronary vasodilatation. The drug may act by antagonizing beta-adrenergic effects.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5954491      PMCID: PMC1935727     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRIL.

Authors:  K I MELVILLE; B G BENFEY
Journal:  Can J Physiol Pharmacol       Date:  1965-03       Impact factor: 2.273

2.  Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium.

Authors:  E D Luebs; A Cohen; E J Zaleski; R J Bing
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

3.  IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION.

Authors:  K I MELVILLE; H E SHISTER; S HUQ
Journal:  Can Med Assoc J       Date:  1964-03-28       Impact factor: 8.262

  3 in total
  4 in total

1.  Reduction of the size of acute, experimental myocardial infarction by Verapamil.

Authors:  W Wende; W Bleifeld; J Meyer; H W Stühlen
Journal:  Basic Res Cardiol       Date:  1975 Mar-Apr       Impact factor: 17.165

2.  Relaxation of coronary arteries by electro-mechanical decoupling or adrenergic stimulation.

Authors:  U Peiper; E Schmidt
Journal:  Pflugers Arch       Date:  1972       Impact factor: 3.657

Review 3.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

4.  Clinical evaluation of verapamil in angina pectoris.

Authors:  G Sandler; G A Clayton; S G Thornicroft
Journal:  Br Med J       Date:  1968-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.